Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins
Status:
Recruiting
Trial end date:
2025-01-08
Target enrollment:
Participant gender:
Summary
This is an open-label whole-body PET/CT study for investigating the value of Al18F-NOTA-FAPI
PET/CT in patients with malignant tumors expressing fibroblast-activated proteins
Phase:
Phase 1
Details
Lead Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences